Article Text

other Versions

Download PDFPDF
Kawasaki disease: a need for earlier diagnosis and treatment
  1. Huon Gray1,
  2. Jacqueline Cornish2
  1. 1National Clinical Director for Heart Disease, NHS England, UK
  2. 2National Clinical Director , Children, Young People and Transition to Adulthood, NHS England, UK
  1. Correspondence to Dr Jacqueline Cornish, Bristol Royal Hospital for Children, Bristol BS2 8BJ, UK; Jacqueline.Cornish{at}UHBristol.nhs.uk

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Kawasaki disease (KD) is now the most common cause of acquired heart disease in children and is becoming more common worldwide. Despite this, some medical practitioners in the UK may be unaware of the disorder and of its potential long-term cardiac complications, which for those affected require a specialist, and uninterrupted lifetime clinical management. Increasing numbers of patients who suffered KD in childhood are transitioning to the care of adult services, where there is less awareness and experience of the disorder than in paediatric services. KD is an inflammatory disorder predominantly of young children which is associated with vasculitis of the coronary arteries, leading to aneurysm formation in up to a third of untreated patients. Even if treated, the range of persistent aneurysms is 3%–5%,1 2 but coronary artery dilation may be found in 30% in the acute stage, especially in the younger age group.2 Those with persistent coronary abnormalities, especially patients with large or giant aneurysms, are at lifelong risk of thrombosis and are at risk of developing stenotic lesions during vascular remodelling, which may lead to myocardial ischaemia, infarction or death. Those with smaller or resolved aneurysms have …

View Full Text

Footnotes

  • Contributors Both authors have contributed to the editorial.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent Not required.

  • Provenance and peer review Not commissioned; internally peer reviewed.

Linked Articles

  • Original article
    Robert M R Tulloh Richard Mayon-White Anthony Harnden Athimalaipet V Ramanan E Jane Tizard Delane Shingadia Colin A Michie Richard M Lynn Michael Levin Orla D Franklin Pippa Craggs Sue Davidson Rebecca Stirzaker Mike Danson Paul A Brogan